• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

All Posts

HomeBlogAll Posts

In vivo biodistribution of amino-functionalized ceria nanoparticles in rats using positron emission tomography.

3 December, 2012 709

Rojas S, Gispert JD, Abad S, Buaki-Sogo M, Victor VM, Garcia H, Herance JR. Mol Pharm. 2012 Dec 3;9(12):3543-50. doi: 10.1021/mp300382n. Epub 2012 Nov 20...

Read more

Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital.

1 December, 2012 676

Fernández-Hidalgo N1, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M, Pahissa A. Clin Microbiol Infect. 2012 Dec;18(12):E522-30...

Read more

Gold nanoparticles supported on nanoparticulate ceria as a powerful agent against intracellular oxidative stress.

25 June, 2012 723

Menchón C, Martín R, Apostolova N, Victor VM, Alvaro M, Herance JR, García H. Small. 2012 Jun 25;8(12):1895-903. https://www.ncbi.nlm.nih.gov/pubmed/?term=Gold+Nanoparticles+Supported+on+Nanoparticulate+Ceria+as+a+Powerful+Agent+against Abstract...

Read more

Rapid and high-yielding cysteine labelling of peptides with N-succinimidyl 4-[18F]fluorobenzoate.

22 June, 2012 705

Abad S, Nolis P, Gispert JD, Spengler J, Albericio F, Rojas S, Herance JR. Chem Commun (Camb). 2012 Jun 21;48(49):6118-20 https://www.ncbi.nlm.nih.gov/pubmed/?term=Rapid+and+high-yielding+cysteine+labelling+of+peptides+with+N-succinimidyl...

Read more

Beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

12 June, 2012 861

Tenbaum SP, Ordóñez-Morán P, Puig I, Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert JD, Mendizabal L, Aguilar S, Cajal SR, Schwartz S Jr, Vivancos A, Espín E, Rojas S, Baselga J, Tabernero J, Muñoz A, Palmer HG. Nat Med.,  2012...

Read more

Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury.

2 May, 2012 754

Peluffo H, Alí-Ruiz D, Ejarque-Ortíz A, Heras-Alvarez V, Comas-Casellas E, Martínez-Barriocanal A, Kamaid A, Alvarez-Errico D, Negro ML, Lago N, Schwartz S Jr, Villaverde A, Sayós J. Brain Pathol. 2012 May;22(3):318-28...

Read more

Vascularized fibular periosteal graft: a new technique to enhance bone union in children.

1 May, 2012 840

Soldado F, Fontecha CG, Barber I, Velez R, Llusa M, Collado D, Rodriguez-Baeza A, Martinez-Ibañez V. J Pediatr Orthop. 2012 Apr-May;32(3):308-13. https://www.ncbi.nlm.nih.gov/pubmed/22411339 Abstract BACKGROUND: The periosteum in children has...

Read more

Villin expression is frequently lost in poorly differentiated colon cancer.

1 April, 2012 745

Arango D, Al-Obaidi S, Williams DS, Dopeso H, Mazzolini R, Corner G, Byun DS, Carr AA, Murone C, Tögel L, Zeps N, Aaltonen LA, Iacopetta B, Mariadason JM. Am J Pathol. 2012 Apr;180(4):1509-21 https://www.ncbi.nlm.nih.gov/pubmed/22349300 Abstract...

Read more

Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors.

2 March, 2012 775

Comas-Casellas E, Martínez-Barriocanal Á, Miró F, Ejarque-Ortiz A, Schwartz S Jr, Martín M, Sayós J. J Biol Chem. 2012 Mar 23;287(13):9682-93. https://www.ncbi.nlm.nih.gov/pubmed/?term=22291008   Abstract Herein we present the cloning and...

Read more

First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology.

18 February, 2012 736

Sánchez O, Llurba E, Marsal G, Domínguez C, Aulesa C, Sánchez-Durán MA, Goya MM, Alijotas-Reig J, Carreras E, Cabero L. Hum Reprod. 2012 Feb;27(2):358-65. https://www.ncbi.nlm.nih.gov/pubmed/?term=22116949 Abstract BACKGROUND: The risk of...

Read more

Brush border Myosin Ia has tumor suppressor activity in the intestine.

31 January, 2012 861

Mazzolini R, Dopeso H, Mateo-Lozano S, Chang W, Rodrigues P, Bazzocco S, Alazzouzi H, Landolfi S, Hernández-Losa J, Andretta E, Alhopuro P, Espín E, Armengol M, Tabernero J, Ramón Y Cajal S, Kloor M, Gebert J, Mariadason JM, Schwartz S Jr...

Read more

Synthesis and In Vivo Evaluation of the Biodistribution of a F-18-Labeled Conjugate Gold-Nanoparticle-Peptide with Potential Biomedical Application

30 January, 2012 863

Simon Guerrero; Jose Raul Herance; Santiago Rojas; Juan F. Mena; Juan Domingo Gispert; Gerardo A. Acosta; Fernando Albericio; Marcelo J. Kogan. BIOCONJUGATE CHEMISTRY. 23 -3, pp. 399 – 408. 03/2012...

Read more
1-10…1314151617…
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
10 days agoby CIBBIM - Nanomedicine0
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
24 February, 2020by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More